Phospholipase A2 receptor antibodies and clinical prognosis in patients with idiopathic membranous nephropathy: an updated systematic review and meta-analysis

J Zhang, Z Fan, P Wang, AH Zhang - Kidney and Blood Pressure …, 2023 - karger.com
Background: Idiopathic membranous nephropathy (IMN) is the most common form of primary
nephrotic syndrome in adults. Antibodies against the M-type phospholipase A2 receptor …

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy

G Stefan, S Stancu, A Zugravu, O Popa, D Zubidat… - Renal …, 2022 - Taylor & Francis
Background The value of anti-phospholipase A2 receptor antibody (anti-PLA2R ab)
monitoring at 3 months after diagnosis in membranous nephropathy (MN) remains …

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with …

Y Guo, N Guo, J Wang, R Wang, L Tang - Renal Failure, 2021 - Taylor & Francis
Introduction Primary membranous nephropathy (PMN) is one common cause of end-stage
kidney disease. There is no optimal treatment for PMN patients with sub-nephrotic …

Diagnostic value of renal biopsy in anti-phospholipase A2 receptor antibody-positive patients with proteinuria in China

S Lu, J Xiao, D Liu, Y Zhang, Y Dong, Z Zhao - Scientific Reports, 2024 - nature.com
Renal biopsy remains the gold standard for diagnosing membranous nephropathy (MN).
Recent studies have suggested that renal biopsy can be replaced with the serum …

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels

Y Sun, P Lan, J Feng, Z Wang, C Liu, L Xie, X Yu - Renal Failure, 2022 - Taylor & Francis
Objective To verify glomerular PLA2R antigen and serum PLA2R antibody expression in
membranous nephropathy as well as to explore glomerular PLA2R efficacy in evaluating the …

[HTML][HTML] A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy

F Wang, J Xu, F Wang, X Yang, Y Xia… - … and Decision Making, 2024 - ncbi.nlm.nih.gov
Background Because spontaneous remission is common in IMN, and there are adverse
effects of immunosuppressive therapy, it is important to assess the risk of progressive loss of …

Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies

X Li, Y Shen, Y Li, L Ma, Q Sun - Renal Failure, 2024 - Taylor & Francis
Background Idiopathic membranous nephropathy (IMN) with deposits of phospholipase A2
receptor (PLA2R) antigen in glomerular tissue (GAg+) but no circulating serum PLA2R …

Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders

D Deleersnijder, W Laurens, J De Meester… - Clinical Kidney …, 2023 - academic.oup.com
ABSTRACT Background The Flemish Collaborative Glomerulonephritis Group (FCGG)
registry provides complete population data on kidney disease epidemiology in the region of …

Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium

D Deleersnijder, N Knops, D Trouet, K Van Hoeck… - Pediatric …, 2023 - Springer
Abstract Background The Flemish Collaborative Glomerulonephritis Group (FCGG) registry
is a population-based kidney biopsy registry that has been including all native kidney …

[HTML][HTML] Clinical characteristics of membranous nephropathy with spontaneous remission: An analysis of 24 patients

X Wang, J Zhang, G Zou, X Zheng, J Li, H Gao, S Jiang… - Medicina Clínica, 2023 - Elsevier
Purpose To investigate the prognosis of patients with spontaneous remission (SR) of
phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN). Patients …